Patent directory · USPTO A61K / A61P
Patents matching “The United States of America”
3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9931377
Cell expressing complexes of IL-15 and IL-15Ralpha
granted -
US 9932406
Human monoclonal antibodies specific for glypican-3 and use thereof
granted -
US 9919040
Soluble recombinant plasmodium falciparum circumsporozoite protein, use in vaccines, methods of making and uses thereof
granted -
US 9919058
Polyketal particles including a CpG oligodeoxynucleotide for the treatment of lung cancer
granted -
US 9920296
Paenibacillus alvei strain TS-15 and its use in controlling pathogenic organisms on crops
granted -
US 9914773
Anti-human folate receptor beta antibodies and methods of use
granted -
US 9913892
Materials and methods for respiratory disease control in canines
granted -
US 9908841
Preparation of (R,R)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure
granted -
US 9902734
Nicotinic acetylcholine receptor agonists
granted -
US 9896511
Antibodies that bind to TL1A and methods of treating inflammatory or autoimmune disease comprising administering such antibodies
granted -
US 9896509
Use of antagonists of the interaction between HIV GP120 and α4β7 integrin
granted -
US 9896484
Influenza virus recombinant proteins
granted -
US 9889115
Fitness assay and associated methods
granted -
US 9890369
Cytolethal distending toxin subunit B conjugated or fused to Bacillus anthracis toxin lethal factor
granted -
US 9884100
Lutzomyia longipalpis polypeptides and methods of use
granted -
US 9884104
Live attenuated virus vaccines for la crosse virus and other bunyaviridae
granted -
US 9879231
Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertion sites
granted -
US 9879065
T cell receptors recognizing MHC class II-restricted MAGE-A3
granted -
US 9873702
Heterocyclic compounds as biogenic amine transport modulators
granted -
US 9873893
Methods and compositions for treating genetically linked diseases of the eye
granted -
US 9868943
Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB—SauS-philPLA88 virion-associated peptidoglycan hydrolase HydH5: fusions, deletions and synergy with LysH5
granted -
US 9868954
Reduction of TGFβ signaling in myeloid cells in the treatment of cancer
granted -
US 9868769
Mutated Salmonella enteriaca
granted -
US 9868774
Anti-CD22 chimeric antigen receptors
granted